Works matching IS 22351795 AND DT 2021 AND VI 10 AND IP 6
Results: 12
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 1, doi. 10.1159/000520799
- Publication type:
- Article
Contents Vol. 10, 2021.
- Published in:
- 2021
- Publication type:
- Table of Contents
Acknowledgement to Reviewers.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 641, doi. 10.1159/000520214
- Publication type:
- Article
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 583, doi. 10.1159/000519108
- By:
- Publication type:
- Article
Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 572, doi. 10.1159/000518728
- By:
- Publication type:
- Article
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 561, doi. 10.1159/000518297
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 545, doi. 10.1159/000518104
- By:
- Publication type:
- Article
Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 606, doi. 10.1159/000518090
- By:
- Publication type:
- Article
Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 615, doi. 10.1159/000518048
- By:
- Publication type:
- Article
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 629, doi. 10.1159/000517393
- By:
- Publication type:
- Article
Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 593, doi. 10.1159/000516957
- By:
- Publication type:
- Article